Medical and Ethical Dilemmas when an Advanced Cancer Patient Discontinues Dialysis

Folstein MF , Folstein S , McHugh PR . Mini-mental state: a practical method of grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189–198.

Brown JH , Henteleff P , Barakat S , Rowe JR . Is it normal for terminally ill patients to desire death? Am J Psychiatry 1986; 143: 208–211.

Chochinov HM , Wilson KG , Enns M , Mowchun N , Lander S , Levitt M , . Desire for death in the terminally ill. Am J Psychiatry 1995; 152: 1185–1191.

Chochinov HM , Tataryn D , Clinch J , Dudgeon D. Will to live in the terminally ill. Lancet 1999; 354: 816–819.

Chochinov HM , Wilson KG , Enns M , Lander S. Depression, hopelessness, and suicidal ideation in the terminally ill. Psychosomatics 1998; 39: 366–370.

Wilson K , Scott JF , Graham ID , Kozak JF , Chater S , Viola RA , . Attitudes of terminally ill patients toward euthanasia and physician-assisted suicide. Arch Int Med 2000; 160: 2454–2460.

Emanual EJ , Fairclough DL , Emanual LL . Attitudes and desires related to euthanasia and physician-assisted suicide among terminally ill patients and their caregivers. JAMA 2000; 284: 2460–2468.

Breitbart W , Rosenfeld B , Pessin H , Kaim M , Funesti-Esch J , Galietta M , . Depression, hopelessness, and desire for hastened death in terminally ill patients with cancer. JAMA 2000; 284: 2907–2911.

Woods SW , Tesar GE , Murray GB , Cassem NH . Psychostimulant treatment of depressive disorders secondary to medical illness. J Clin Psychiatry 1986; 47: 12–15.

Fernandez F , Adams F , Holmes VF , Levy JK , Neidhart M. Methylphenidate for depressive disorders in cancer patients. Psychosomatics 1987; 28: 455–461.

Breitbart W , Mermelstein H. Pemoline: an alternative psychostimulant for the management of depressive disorders in cancer patients. Psychosomatics 1992; 33: 352–356.

Burns MM , Eisendrath SJ . Dextroamphetamine treatment for depression in terminally ill patients. Psychosomatics 1994; 3: 83.

Guay DR , Awni WM , Findlay JW , Halstenson CE , Abraham PA , Opshal JA , . Pharmacokinetics and pharmcodynamics of codeine in end-stage renal disease. Clin Pharmacol Ther 1988; 43 (1):63–71.

D'Honneur G , Gilton A , Sandouk P , Scherrmann JM , Duvaldestin P. Plasma and cerebrospinal fluid concentrations of morphine and morphine glucuronides after oral morphine: the influence of renal failure. Anesthesiology 1994; 81: 87–93.

Tiseo PJ , Thaler HT , Lapin J , Inturrisi CE , Portenoy RK , Foley KM . Morphine-6-glucuronide concentrations and opioid-related side effects: a survey in cancer patients Pain 1995; 61: 47–54.

Babul N , Darke AC , Hagen N. Hydromorphone metabolite accumulation in renal failure. J Pain Symptom Manage 1995; 10: 184–186.

Mather LE . Clinical pharmacokinetics of fentanyl and its newer derivatives. Clin Pharmacokinet 1983; 8: 422–446.

Singer M , Rogers Noonan K. Continuous intravenous infusion of fentanyl: case reports of use in patients with advanced cancer and intractable pain. J Pain Symptom Manage 1993; 8: 215–220.

Watanabe S , Pereira J , Hanson J , Bruera E. Fentanyl by continuous subcutaneous infusion for the management of cancer pain: a retrospective study. J Pain Symptom Manage 1998; 16: 323–326.

Chauvin M , Sandouk P , Scherrmann JM , Farinotti R , Strumza P , Duvaldestin P. Morphine pharmacokinetics in renal failure. Anesthesiology 1987; 6 (3):327–331.

Pauli-Magnus C , Hofmann U , Mikus G. Kuhlmann U, Mettang T. Pharmacokinetics of morphine and its’ glucuronides following intravenous administration of morphine in patients undergoing continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1999; 14 (4):903–909.

Pereira J , Bruera E. Emerging neuropsychiatric toxicities of opioids. J Pharmaceutical Care in Pain and Symptom Control 1997; 5: 3–29.

de Stoutz N , Bruera E , Suarez-Almazor M. Opioid rotation for toxicity reduction in terminal cancer patients. J Pain Symptom Manage 1995; 10: 378–384.

Fainsinger R , Schoeller T , Bruera E. Methadone in the management of cancer pain: a review. Pain 1993; 52: 137–147.

Ripamonti C , Zecca E , Bruera E. An update on the clinical use of methadone for cancer pain. Pain 1997; 70: 109–115.

Bruera E , Neumann CM . Role of methadone in the management of pain in cancer patients. Oncology 1999; 13: 1275–1282.

Cohen LM , McCue JD , Germain M , Kjellstrand CM . Dialysis discontinuation: a ‘good’ death? Arch Intern Med 1995; 155: 42–47.

Cohen LM , Germain MJ , Poppel DM , Woods AL , Pekow PS , Kjellstrand CM . Dying well after discontinuing the life-support treatment of dialysis. Arch Intern Med 2000; 160 (16):2513–2518.

Johnson Neely K , Roxe DM . Palliative care/hospice and the withdrawal of dialysis. J Palliat Med 2000; 3 (1):57–67.

Lawlor P , Gagnon B , Mancini I , Pereira J , Hanson J , Suarez-Almazor M , Bruera E. Occurrence, causes, and outcome of delirium in patients with advanced cancer. Arch Intern Med 2000; 160: 786–794.

Borreani C , Caraceni A , Tamburini M. Counseling the confused patient and family. In: Portenoy R , Bruera E (eds). Topics in Palliative Care. Volume I. New York: Oxford University Press, 1997; pp. 45–54.

Kilner JF . Ethical issues in the initiation and termination of treatment. Am J Kidney Dis 1990; 15: 218–227.

Ferrando SJ . Ethics rounds, commentary: integrating consultation-liaison psychiatry and palliative care. J Pain Symptom Manage 2000;20(3):235–236.

Rodin GM , Chmara J , Ennis J , Fenton S , Locking H , Steinhouse K. Stopping life-sustaining medical treatment: psychiatric considerations in the termination of renal dialysis. Can J Psychiatry 1981; 26: 540–544.

Sullivan MD , Younger SJ . Depression, competence, and the right to refuse lifesaving medical treatment. Am J Psychiatry 1994; 151: 971–978.

Kissane DW , Clarke DM , Street AF . Demoralization syndrome—a relevant psychiatric diagnosis for palliative care. J Palliat Care 2001; 17: 12–21.